{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:30:47Z","timestamp":1793403047486,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The objective of this study is to investigate the predictive ability of abdominal fat features derived from computed tomography (CT) to predict early recurrence within a year following the initial transurethral resection of bladder tumor (TURBT) in patients with non-muscle-invasive bladder cancer (NMIBC). A predictive model is constructed in combination with clinical factors to aid in the evaluation of the risk of early recurrence among patients with NMIBC after initial TURBT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study enrolled 325 NMIBC patients from three centers. Machine learning\u2013based visceral adipose tissue (VAT) radiomics models (VAT-RM) and subcutaneous adipose tissue (SAT) radiomics models (SAT-RM) were constructed to identify patients with early recurrence. A combined model integrating VAT-RM and clinical factors was established. The predictive performance of each variable and model was analyzed using the area under the receiver operating characteristic curve (AUC). The net benefit of each variable and model was presented through decision curve analysis (DCA). The calibration was evaluated utilizing the Hosmer\u2013Lemeshow test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings:<\/jats:title>\n                    <jats:p>\n                      The VAT-RM demonstrated satisfactory performance in the training cohort (AUC\u00a0=\u00a00.853; 95% CI: 0.768\u20130.937), test cohort 1 (AUC\u00a0=\u00a00.823; 95% CI: 0.730\u20130.916), and test cohort 2 (AUC\u00a0=\u00a00.808; 95% CI: 0.681\u20130.935). Across all cohorts, the AUC values of the VAT-RM were higher than those of the SAT-RM (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001). The DCA curves further confirmed that the clinical net profit of the VAT-RM was superior to that of the SAT-RM. In multivariate logistic regression analysis, the VAT-RM emerged as the most significant independent predictor [odds ratio (OR)\u00a0=\u00a00.295; 95% CI: 0.141\u20130.508;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;\u00a00.001]. The fusion model exhibited excellent AUC values of 0.938, 0.909, and 0.905 across three cohorts. The fusion model surpassed the traditional risk assessment frameworks in both predictive efficacy and clinical net benefit.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation:<\/jats:title>\n                    <jats:p>VAT serves as a crucial factor in early postoperative recurrence in NMIBC patients. The VAT-RM can accurately identify high-risk patients with early postoperative recurrence, offering significant advantages over SAT-RM. The new predictive model constructed by integrating the VAT-RM and clinical factors exhibits excellent predictive performance, clinical net benefits, and calibration accuracy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003140","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:00:51Z","timestamp":1754917251000},"page":"9457-9470","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["CT-based radiomics signature of visceral adipose tissue for prediction of early recurrence in patients with NMIBC: a multicentre cohort study"],"prefix":"10.1097","volume":"111","author":[{"given":"Nengfeng","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenkai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5048-3262","authenticated-orcid":false,"given":"Xiaodong","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"466\u2013465","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"280\u201394","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer \u2013 a clinical perspective","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat Rev Urol"},{"key":"R3-20261030","first-page":"2796\u2013810","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12885-022-09733-8","article-title":"Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor","volume":"22","author":"Jeong","year":"2022","journal-title":"BMC Cancer"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"e16426","DOI":"10.1097\/MD.0000000000016426","article-title":"Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): a study based on 477 patients","volume":"98","author":"Lu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"36\u201351","DOI":"10.1016\/j.semcancer.2023.05.002","article-title":"Obesity-induced changes in cancer cells and their microenvironment: mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism","volume":"93","author":"Lee-Rueckert","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"155744","DOI":"10.1016\/j.metabol.2023.155744","article-title":"Rising global burden of cancer attributable to high BMI from 2010 to 2019","volume":"152","author":"Tan","year":"2024","journal-title":"Metabolism"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"918330","DOI":"10.3389\/fnut.2022.918330","article-title":"The global burden and temporal trend of cancer attributable to high body mass index: estimates from the Global Burden of Disease Study 2019","volume":"9","author":"Zhi","year":"2022","journal-title":"Front Nutr"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"70\u201398","DOI":"10.1016\/j.semcancer.2023.03.002","article-title":"Obesity and main urologic cancers: current systematic evidence, novel biological mechanisms, perspectives and challenges","volume":"91","author":"Papavasileiou","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"11\u201318","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: structural and functional differences","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"e36569","DOI":"10.1371\/journal.pone.0036569","article-title":"Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell","volume":"7","author":"Baglioni","year":"2012","journal-title":"PLoS One"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"886\u201395","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"4277\u201383","DOI":"10.1200\/JCO.2016.67.9712","article-title":"Obesity and cancer mechanisms: cancer metabolism","volume":"34","author":"Hopkins","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R14-20261030","doi-asserted-by":"crossref","first-page":"148\u201352","DOI":"10.1016\/j.ypmed.2009.06.023","article-title":"Measurement error and ethnic comparisons of measures of abdominal obesity","volume":"49","author":"Dhaliwal","year":"2009","journal-title":"Prev Med"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"110851","DOI":"10.1016\/j.ejrad.2023.110851","article-title":"Fat quantification: imaging methods and clinical applications in cancer","volume":"164","author":"Yan","year":"2023","journal-title":"Eur J Radiol"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"111205","DOI":"10.1016\/j.ejrad.2023.111205","article-title":"Sex differences in abdominal visceral fat composition and metabolism as predictors of DLBCL prognosis: a retrospective cohort study","volume":"170","author":"Wang","year":"2024","journal-title":"Eur J Radiol"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"62\u201368","DOI":"10.1016\/j.ygyno.2023.06.581","article-title":"Visceral fat percentage for prediction of outcome in uterine cervical cancer","volume":"176","author":"Eide","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"101805","DOI":"10.1016\/j.eclinm.2022.101805","article-title":"CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn\u2019s disease: a multicentre cohort study","volume":"56","author":"Li","year":"2022","journal-title":"eClinicalMedicine"},{"key":"R19-20261030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13244-023-01581-9","article-title":"CT-based radiomics signature of visceral adipose tissue and bowel lesions for identifying patients with Crohn\u2019s disease resistant to infliximab","volume":"15","author":"Wang","year":"2024","journal-title":"Insights Imaging"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.acra.2024.09.036","article-title":"Coupling habitat radiomic analysis with the diversification of the tumor ecosystem: illuminating new strategy in the assessment of postoperative recurrence of non-muscle invasive bladder cancer","volume":"32","author":"Li","year":"2025","journal-title":"Acad Radiol"},{"key":"R21-20261030","first-page":"100082","article-title":"Transparency in the reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"387\u201391","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br J Cancer"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"803\u201311","DOI":"10.1093\/jnci\/djy088","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): an abridged explanation and elaboration","volume":"110","author":"Sauerbrei","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R24-20261030","doi-asserted-by":"crossref","first-page":"1323\u201341","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D slicer as an image computing platform for the quantitative imaging network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"1221\u201335","DOI":"10.1016\/j.jcmg.2014.07.017","article-title":"Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study","volume":"7","author":"Shah","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"R26-20261030","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"Van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"20459\u201369","DOI":"10.1002\/cam4.6620","article-title":"Body mass index and waist circumference in relation to risk of recurrence and progression after non-muscle invasive bladder cancer","volume":"12","author":"van Zutphen","year":"2023","journal-title":"Cancer Med"},{"key":"R28-20261030","doi-asserted-by":"crossref","first-page":"480\u201386","DOI":"10.1016\/j.juro.2013.01.089","article-title":"Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder","volume":"190","author":"Kluth","year":"2013","journal-title":"J Urol"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"507\u201314","DOI":"10.1007\/s00345-018-2397-1","article-title":"An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer","volume":"37","author":"Ferro","year":"2019","journal-title":"World J Urol"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"413\u201326","DOI":"10.1038\/s41588-024-02048-3","article-title":"Human subcutaneous and visceral adipocyte atlases uncover classical and nonclassical adipocytes and depot-specific patterns","volume":"57","author":"Lazarescu","year":"2025","journal-title":"Nat Genet"},{"key":"R31-20261030","doi-asserted-by":"crossref","first-page":"3732\u201340","DOI":"10.1245\/s10434-017-6077-y","article-title":"Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer","volume":"24","author":"Okumura","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"1019\u201328","DOI":"10.1007\/s00384-018-3038-2","article-title":"Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer","volume":"33","author":"Kuritzkes","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"R33-20261030","first-page":"5792\u2013801","article-title":"Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer","volume":"40","author":"Ke","year":"2021","journal-title":"Clin Nutr Edinb Scotl"},{"key":"R34-20261030","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.euf.2021.05.005","article-title":"Role of radiomics in the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"8","author":"Kozikowski","year":"2022","journal-title":"Eur Urol Focus"},{"key":"R35-20261030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12967-023-04437-4","article-title":"Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis","volume":"21","author":"Kang","year":"2023","journal-title":"J Transl Med"},{"key":"R36-20261030","doi-asserted-by":"crossref","first-page":"563\u201377","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"R37-20261030","doi-asserted-by":"crossref","first-page":"328\u201338","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"R38-20261030","doi-asserted-by":"crossref","first-page":"2195\u2013203","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with Bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"R39-20261030","doi-asserted-by":"crossref","first-page":"111025","DOI":"10.1016\/j.ejrad.2023.111025","article-title":"Adipose distribution patterns as prognostic factors in patients with HCC: a systematic review and meta-analysis","volume":"167","author":"Shi","year":"2023","journal-title":"Eur J Radiol"},{"key":"R40-20261030","doi-asserted-by":"crossref","first-page":"480\u201388","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"R41-20261030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.euo.2021.11.006","article-title":"Updated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu\u00e9rin","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"R42-20261030","doi-asserted-by":"crossref","first-page":"102199","DOI":"10.1016\/j.clgc.2024.102199","article-title":"Characteristics of abdominal fat based on CT measurements to predict early recurrence after initial surgery of NMIBC in stage Ta\/T1","volume":"22","author":"Yu","year":"2024","journal-title":"Clin Genitourin Cancer"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000003140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:02:29Z","timestamp":1793401349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000003140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003140","relation":{},"ISSN":["1743-9159","1743-9191"],"issn-type":[{"value":"1743-9159","type":"electronic"},{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"2025-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}